简介：Anti-viral for HCC: It could be assumed that the anti-viral could be only for prevention. However, our data clearly indicated that the eradication of HCV in patients who already developed HCC were also beneficial to prolong the patients' life. Now, we are able to expect 80% 5-year survival rate in the combination of RFA and the eradication of HCV.